72 related articles for article (PubMed ID: 9486562)
1. Effect of terminal renal failure on the ratio of free to total prostate-specific antigen.
Douville P; Tiberi M
Tumour Biol; 1998; 19(2):113-7. PubMed ID: 9486562
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of total and free prostate specific antigen in men on hemodialysis.
Sasagawa I; Kubota Y; Hayami S; Adachi M; Nakada T; Miura H; Imai K
J Urol; 1998 Jul; 160(1):83-5. PubMed ID: 9628610
[TBL] [Abstract][Full Text] [Related]
3. Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment.
Bruun L; Björk T; Lilja H; Becker C; Gustafsson O; Christensson A
Nephrol Dial Transplant; 2003 Mar; 18(3):598-603. PubMed ID: 12584285
[TBL] [Abstract][Full Text] [Related]
4. Do renal failure and hemodialysis have any effect on the elimination of free and total prostate-specific antigen?
Danişman A; Kiliç S; Kukul E; Yakupoğlu G; Güntekin E; Baykara M; Sevük M
Eur Urol; 2000 May; 37(5):579-81. PubMed ID: 10765097
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen in hemodialysis patients and the influence of dialysis in its levels.
Tzanakis I; Kazoulis S; Girousis N; Kagia S; Spandidakis V; Karefillakis N; Georgila M; Cristoulakis I; Hatzilias P; Kallivretakis N
Nephron; 2002 Feb; 90(2):230-3. PubMed ID: 11818714
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer screening with prostate-specific antigen in hemodialysis patients.
Horinaga M; Kitamura K; Saito S; Ukimura O; Nakanoma T; Okihara K; Kitagawa M; Nakanishi H; Miki T
Urol Int; 2007; 78(4):334-7. PubMed ID: 17495492
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of prostate specific antigen in men on hemodialysis.
Wolff JM; Ting O; Borchers H; Rohde D; Jakse G
Anticancer Res; 2000; 20(6D):5191-3. PubMed ID: 11326693
[TBL] [Abstract][Full Text] [Related]
8. Effects of hemodialysis on prostate-specific antigen.
Monath JR; Burkart JM; Freedman BI; Pittaway DE; Russell GB; Assimos DG
Urology; 1993 Oct; 42(4):398-400. PubMed ID: 7692660
[TBL] [Abstract][Full Text] [Related]
9. Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer.
Ellis WJ; Etzioni R; Vessella RL; Hu C; Goodman GE
J Urol; 2001 Jul; 166(1):93-8; discussion 98-9. PubMed ID: 11435831
[TBL] [Abstract][Full Text] [Related]
10. Screening for prostate cancer using prostate-specific antigen testing in Japanese men on hemodialysis.
Kurahashi T; Miyake H; Shinozaki M; Oka N; Takenaka A; Hara I; Matsumura Y; Fujisawa M
Int Urol Nephrol; 2008; 40(2):345-9. PubMed ID: 17619159
[TBL] [Abstract][Full Text] [Related]
11. Effect of kidney transplantation on early and late post-transplant prostate-specific antigen levels.
Mahdavi R; Zeraati A; Tavakkoli M; Aghamohammadpour K; Ghoreifi A
Saudi J Kidney Dis Transpl; 2014 Mar; 25(2):362-6. PubMed ID: 24626004
[TBL] [Abstract][Full Text] [Related]
12. Effect of hemodialysis on serum complexed prostate-specific antigen levels.
Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoglu U
Scand J Urol Nephrol; 2007; 41(5):382-6. PubMed ID: 17853041
[TBL] [Abstract][Full Text] [Related]
13. PSA levels in patients on hemodialysis treatment.
García-Sánchez C; Corchuelo-Maillo C; Congregado-Ruiz CB; Ocón-Revuelta EM; Osman-García I; Conde-Sánchez JM; Medina-López RA
Arch Esp Urol; 2013 Dec; 66(10):939-44. PubMed ID: 24369188
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.
Lein M; Jung K; Elgeti U; Petras T; Stephan C; Brux B; Sinha P; Winkelmann B; Schnorr D; Loening S
Eur Urol; 2001 Jan; 39(1):57-64. PubMed ID: 11173940
[TBL] [Abstract][Full Text] [Related]
15. Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia.
Paus E; Nilsson O; Børmer OP; Fosså SD; Otnes B; Skovlund E
J Urol; 1998 May; 159(5):1599-605. PubMed ID: 9554362
[TBL] [Abstract][Full Text] [Related]
16. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.
Brawer MK; Cheli CD; Neaman IE; Goldblatt J; Smith C; Schwartz MK; Bruzek DJ; Morris DL; Sokoll LJ; Chan DW; Yeung KK; Partin AW; Allard WJ
J Urol; 2000 May; 163(5):1476-80. PubMed ID: 10751861
[TBL] [Abstract][Full Text] [Related]
17. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
18. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate.
Jung K; Meyer A; Lein M; Rudolph B; Schnorr D; Loening SA
J Urol; 1998 May; 159(5):1595-8. PubMed ID: 9554361
[TBL] [Abstract][Full Text] [Related]
19. Utility of free/total prostate specific antigen (f/t PSA) ratio in diagnosis of prostate carcinoma.
Thakur V; Singh PP; Talwar M; Mukherjee U
Dis Markers; 2003-2004; 19(6):287-92. PubMed ID: 15258330
[TBL] [Abstract][Full Text] [Related]
20. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
Haese A; Dworschack RT; Partin AW
J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
